Vertex Pharmaceuticals
VRTX
#185
Rank
A$169.26 B
Marketcap
A$660.19
Share price
0.56%
Change (1 day)
-1.67%
Change (1 year)

Market capitalization of Vertex Pharmaceuticals (VRTX)

Market cap: A$169.26 Billion

As of January 2026 Vertex Pharmaceuticals has a market cap of A$169.26 Billion. This makes Vertex Pharmaceuticals the world's 185th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Vertex Pharmaceuticals from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026A$169.26 B-4.47%
2025A$177.19 B4.7%
2024A$169.24 B9.97%
2023A$153.89 B41.28%
2022A$108.92 B41.3%
2021A$77.08 B-3.55%
2020A$79.92 B-1.32%
2019A$80.99 B34.94%
2018A$60.02 B23.64%
2017A$48.54 B91.51%
2016A$25.34 B-40.42%
2015A$42.54 B21.22%
2014A$35.09 B80.21%
2013A$19.47 B122.28%
2012A$8.76 B29.69%
2011A$6.75 B-3.75%
2010A$7.01 B-26.41%
2009A$9.53 B56.51%
2008A$6.09 B72.62%
2007A$3.53 B-41.03%
2006A$5.98 B46.38%
2005A$4.08 B270.74%
2004A$1.10 B1.54%
2003A$1.08 B-49.42%
2002A$2.14 B-40.6%
2001A$3.61 B-52.56%
2000A$7.62 B457.24%
1999A$1.36 B11.03%
1998A$1.23 B-3.53%
1997A$1.27 B19.49%
1996A$1.06 B

End of Day market cap according to different sources

On Jan 16th, 2026 the market cap of Vertex Pharmaceuticals was reported to be:

A$167.50 Billion
by Nasdaq info icon info icon
A$169.26 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
A$231.83 B 36.96%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$566.66 B 234.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$406.60 B 140.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$168.27 B-0.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$788.01 B 365.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
A$0.54 B-99.68%๐Ÿ‡บ๐Ÿ‡ธ USA